Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has updated its version to v2.16.5, while the previous version v2.16.4 has been removed. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    5%
    Check dated 2025-07-04T13:10:55.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-20T06:39:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T00:53:15.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T20:52:25.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T15:40:44.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T02:20:14.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.